Cody A. Chastain

2.0k total citations
34 papers, 565 citations indexed

About

Cody A. Chastain is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Cody A. Chastain has authored 34 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in Cody A. Chastain's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Cody A. Chastain is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Cody A. Chastain collaborates with scholars based in United States and India. Cody A. Chastain's co-authors include David J. Weber, Charles Poole, Jonathan J. Juliano, Nada El Husseini, Til Stürmer‎, John R. Perfect, Michael S. Lee, Andrew Douglas, Lori Shutter and Leena Choi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Cody A. Chastain

32 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cody A. Chastain United States 11 400 249 115 91 48 34 565
Karthick Rajendran India 9 94 0.2× 223 0.9× 46 0.4× 86 0.9× 28 0.6× 45 452
S Bevilacqua France 9 333 0.8× 249 1.0× 199 1.7× 61 0.7× 27 0.6× 15 616
Mercedes Márquez-Coello Spain 10 178 0.4× 55 0.2× 124 1.1× 12 0.1× 41 0.9× 23 378
Andrea Mastrángelo Italy 10 78 0.2× 170 0.7× 22 0.2× 35 0.4× 10 0.2× 21 380
Anna Boroń‐Kaczmarska Poland 14 490 1.2× 160 0.6× 466 4.1× 8 0.1× 76 1.6× 64 751
GJ Moyle United Kingdom 6 102 0.3× 274 1.1× 24 0.2× 61 0.7× 54 1.1× 13 529
Van Hung Pham Vietnam 13 154 0.4× 131 0.5× 78 0.7× 35 0.4× 23 0.5× 37 423
Rashed S. Al-Rashed Saudi Arabia 14 445 1.1× 92 0.4× 409 3.6× 48 0.5× 105 2.2× 30 671
George Khechinashvili United States 10 289 0.7× 251 1.0× 46 0.4× 51 0.6× 145 3.0× 13 457
Kazem Kazempour United States 9 91 0.2× 99 0.4× 13 0.1× 10 0.1× 17 0.4× 11 399

Countries citing papers authored by Cody A. Chastain

Since Specialization
Citations

This map shows the geographic impact of Cody A. Chastain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cody A. Chastain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cody A. Chastain more than expected).

Fields of papers citing papers by Cody A. Chastain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cody A. Chastain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cody A. Chastain. The network helps show where Cody A. Chastain may publish in the future.

Co-authorship network of co-authors of Cody A. Chastain

This figure shows the co-authorship network connecting the top 25 collaborators of Cody A. Chastain. A scholar is included among the top collaborators of Cody A. Chastain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cody A. Chastain. Cody A. Chastain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Nadia, Sarit A. Golub, Cody A. Chastain, et al.. (2024). Long‐acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI UP Project. Journal of the International AIDS Society. 27(S1). e26282–e26282. 8 indexed citations
2.
Golub, Sarit A., et al.. (2024). Developing a Practice-Driven Taxonomy of Implementation Strategies for HIV Prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(4). 377–385. 1 indexed citations
3.
4.
Person, Anna K., et al.. (2023). Interprofessional Education: An Innovative Approach to Increase the Human Immunodeficiency Virus Workforce. Open Forum Infectious Diseases. 10(11). ofad560–ofad560.
5.
Colgrove, Robert C., Lou Ann Bruno‐Murtha, Cody A. Chastain, et al.. (2022). Tale of the Titers: Serologic Testing for SARS-CoV-2—Yes, No, and Maybe, With Clinical Examples From the IDSA Diagnostics Committee. Open Forum Infectious Diseases. 10(1). ofac674–ofac674. 3 indexed citations
6.
Chastain, Cody A., Cathy A. Jenkins, Daniel B. Moore, et al.. (2022). Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region. SHILAP Revista de lepidopterología. 3(5). e12819–e12819. 2 indexed citations
7.
Wurcel, Alysse G., Jessica Wolpaw Reyes, Keki Balsara, et al.. (2022). Surgeons’ Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis. The Annals of Thoracic Surgery. 116(3). 492–498. 5 indexed citations
8.
Ryan, Michael S., A Khan, Yoon Soo Park, et al.. (2021). Workplace-Based Entrustment Scales for the Core EPAs: A Multisite Comparison of Validity Evidence for Two Proposed Instruments Using Structured Vignettes and Trained Raters. Academic Medicine. 97(4). 544–551. 8 indexed citations
9.
10.
Zuckerman, Autumn D., et al.. (2019). Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?. PLoS ONE. 14(11). e0225434–e0225434. 6 indexed citations
11.
Chastain, Cody A., et al.. (2019). A Clinical Review of Diabetic Foot Infections. Clinics in Podiatric Medicine and Surgery. 36(3). 381–395. 41 indexed citations
12.
Douglas, Andrew, et al.. (2018). Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era. PLoS ONE. 13(6). e0199174–e0199174. 65 indexed citations
13.
Carver, Alicia, et al.. (2018). Building a Hepatitis C Clinical Program: Strategies to Optimize Outcomes. Current treatment options in infectious diseases. 10(4). 431–446. 12 indexed citations
14.
Zuckerman, Autumn D., Cody A. Chastain, & Susanna Naggie. (2017). Retreatment Options Following HCV Direct-Acting Antiviral Failure. Current treatment options in infectious diseases. 9(4). 389–402. 8 indexed citations
15.
Chastain, Cody A., Susan E. Beekmann, Erika Wallender, et al.. (2015). Hepatitis C Management and the Infectious Diseases Physician: A Survey of Current and Anticipated Practice Patterns: Figure 1.. Clinical Infectious Diseases. 61(5). 792–794. 8 indexed citations
16.
Jones, Whitney, Cody A. Chastain, & Patty W. Wright. (2014). Iatrogenic Cushing Syndrome Secondary to a Probable Interaction Between Voriconazole and Budesonide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(7). e116–9. 18 indexed citations
17.
Chastain, Cody A. & Susanna Naggie. (2013). Treatment of Genotype 1 HCV Infection in the HIV Coinfected Patient in 2014. Current HIV/AIDS Reports. 10(4). 408–419. 16 indexed citations
18.
Husseini, Nada El, Cody A. Chastain, Michael S. Lee, et al.. (2012). Correction: Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant. PLoS ONE. 7(10). 23 indexed citations
19.
Chen, Luke F., Cody A. Chastain, & Deverick J. Anderson. (2011). Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention. Current Infectious Disease Reports. 13(5). 442–450. 11 indexed citations
20.
Chastain, Cody A., et al.. (2007). Transforaminal Lumbar Interbody Fusion: A Retrospective Study of Long-term Pain Relief and Fusion Outcomes. Orthopedics. 30(5). 389–392. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karthick Rajendran Breakdown of academic impact, for papers by S Bevilacqua Breakdown of academic impact, for papers by Mercedes Márquez-Coello Breakdown of academic impact, for papers by Andrea Mastrángelo Breakdown of academic impact, for papers by Anna Boroń‐Kaczmarska Breakdown of academic impact, for papers by GJ Moyle Breakdown of academic impact, for papers by Van Hung Pham Breakdown of academic impact, for papers by Rashed S. Al-Rashed Breakdown of academic impact, for papers by George Khechinashvili Breakdown of academic impact, for papers by Kazem Kazempour
Rankless by CCL
2026